D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
GE Vernova
GEV
|
+$601M |
| 2 |
Walt Disney
DIS
|
+$510M |
| 3 |
Palantir
PLTR
|
+$502M |
| 4 |
Financial Select Sector SPDR Fund
XLF
|
+$490M |
| 5 |
TSMC
TSM
|
+$396M |
Top Sells
| 1 |
Boeing
BA
|
+$967M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$951M |
| 3 |
SPDR S&P 500 ETF Trust
SPY
|
+$567M |
| 4 |
Eli Lilly
LLY
|
+$551M |
| 5 |
Arthur J. Gallagher & Co
AJG
|
+$499M |
Sector Composition
| 1 | Technology | 20.32% |
| 2 | Healthcare | 13% |
| 3 | Consumer Discretionary | 12.32% |
| 4 | Financials | 8.62% |
| 5 | Industrials | 7.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
951
Booz Allen Hamilton
BAH
$12.8B
| $9.02M | 0.01% |
+86,253
| New | +$9.02M |
|
952
Vipshop
VIPS
$9.12B
| $9.02M | 0.01% |
575,084
-447,377
| -44% | -$7.01M |
|
953
World Kinect Corp
WKC
$1.42B
| $9.01M | 0.01% |
317,590
+194,172
| +157% | +$5.51M |
|
954
H.B. Fuller
FUL
$3.39B
| $9.01M | 0.01% |
160,486
+103,186
| +180% | +$5.79M |
|
955
Krystal Biotech
KRYS
$4.04B
| $9M | 0.01% |
49,892
+42,465
| +572% | +$7.66M |
|
956
ICU Medical
ICUI
$3.32B
| $8.97M | 0.01% |
+64,619
| New | +$8.97M |
|
957
Affiliated Managers Group
AMG
$6.69B
| $8.95M | 0.01% |
53,243
-16,879
| -24% | -$2.84M |
|
|
JACS
958
Jackson Acquisition Company II
JACS
| $8.94M | 0.01% |
+888,000
| New | +$8.94M |
|
959
Methode Electronics
MEI
$291M
| $8.91M | 0.01% |
1,395,994
-61,462
| -4% | -$392K |
|
|
HVII
960
Hennessy Capital Investment Corp. VII Ordinary Shares
HVII
| $8.89M | 0.01% |
+899,662
| New | +$8.89M |
|
961
ATN International
ATNI
$240M
| $8.88M | 0.01% |
437,435
+4,732
| +1% | +$96.1K |
|
962
Birkenstock
BIRK
$8.71B
| $8.87M | 0.01% |
193,409
-37,561
| -16% | -$1.72M |
|
|
ALDF
963
Aldel Financial II Inc. Class A Ordinary Shares
ALDF
$312M
| $8.86M | 0.01% |
877,644
+677,715
| +339% | +$6.84M |
|
|
NAGE
964
Niagen Bioscience, Inc. Common Stock
NAGE
$768M
| $8.86M | 0.01% |
1,283,790
+272,500
| +27% | +$1.88M |
|
965
Kiniksa Pharmaceuticals
KNSA
$2.69B
| $8.83M | 0.01% |
397,745
+77,738
| +24% | +$1.73M |
|
966
Compass
COMP
$4.98B
| $8.83M | 0.01% |
1,011,412
-657,438
| -39% | -$5.74M |
|
967
Steven Madden
SHOO
$2.28B
| $8.8M | 0.01% |
330,462
+294,949
| +831% | +$7.86M |
|
|
OACC
968
Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share
OACC
$257M
| $8.79M | 0.01% |
+861,625
| New | +$8.79M |
|
|
RANG
969
Range Capital Acquisition Corp. Ordinary Shares
RANG
$165M
| $8.74M | 0.01% |
+870,000
| New | +$8.74M |
|
970
Autoliv
ALV
$9.77B
| $8.74M | 0.01% |
98,766
+69,787
| +241% | +$6.17M |
|
971
Enerpac Tool Group
EPAC
$2.31B
| $8.71M | 0.01% |
194,248
-26,229
| -12% | -$1.18M |
|
972
Excelerate Energy
EE
$762M
| $8.71M | 0.01% |
303,747
-131,546
| -30% | -$3.77M |
|
973
Albany International
AIN
$1.79B
| $8.7M | 0.01% |
126,028
+50,506
| +67% | +$3.49M |
|
974
Louisiana-Pacific
LPX
$6.75B
| $8.67M | 0.01% |
94,304
-44,679
| -32% | -$4.11M |
|
975
TripAdvisor
TRIP
$2.08B
| $8.67M | 0.01% |
611,926
-587,006
| -49% | -$8.32M |
|